DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 50 filers reported holding DEPOMED INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $33,000 | -5.7% | 45,000 | 0.0% | 0.00% | – |
| Q1 2019 | $35,000 | +16.7% | 45,000 | 0.0% | 0.00% | – |
| Q4 2018 | $30,000 | -18.9% | 45,000 | 0.0% | 0.00% | – |
| Q2 2018 | $37,000 | -98.5% | 45,000 | -98.2% | 0.00% | -100.0% |
| Q1 2017 | $2,397,000 | +34.4% | 2,567,000 | +63.8% | 0.00% | +50.0% |
| Q4 2016 | $1,784,000 | -7.5% | 1,567,000 | +15.7% | 0.00% | 0.0% |
| Q3 2016 | $1,928,000 | -82.1% | 1,354,000 | -84.8% | 0.00% | -85.7% |
| Q2 2016 | $10,761,000 | +80.7% | 8,916,000 | +39.2% | 0.01% | +55.6% |
| Q1 2016 | $5,955,000 | -8.0% | 6,403,000 | +11.8% | 0.01% | +12.5% |
| Q4 2015 | $6,474,000 | -55.9% | 5,729,000 | -53.5% | 0.01% | -55.6% |
| Q3 2015 | $14,668,000 | +431.4% | 12,326,000 | +489.5% | 0.02% | +500.0% |
| Q1 2015 | $2,760,000 | -3.4% | 2,091,000 | -21.7% | 0.00% | 0.0% |
| Q4 2014 | $2,857,000 | -12.9% | 2,670,000 | -14.6% | 0.00% | 0.0% |
| Q3 2014 | $3,281,000 | – | 3,125,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RAVEN ROCK CAPITAL MANAGEMENT, LLC | 4,000,000 | $5,148,000 | 11.77% |
| Mohican Financial Management, LLC | 6,000,000 | $7,687,000 | 4.77% |
| Sage Capital Management, LLC | 2,340,000 | $3,008,000 | 3.90% |
| LINDEN ADVISORS LP | 23,168,000 | $29,773,000 | 3.54% |
| Myriad Asset Management Ltd. | 12,500,000 | $16,103,000 | 1.83% |
| BASSO CAPITAL MANAGEMENT, L.P. | 5,850,000 | $7,510,000 | 1.15% |
| ARISTEIA CAPITAL, L.L.C. | 23,000,000 | $29,610,000 | 1.08% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,435,000 | $42,967,000 | 0.98% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $10,250,000 | 0.89% |
| MACKAY SHIELDS LLC | 12,114,000 | $15,538,000 | 0.80% |